| 000 | 01403 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515130119.0 | ||
| 264 | 0 | _c20081014 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1462-0332 | ||
| 024 | 7 |
_a10.1093/rheumatology/ken240 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaul, A | |
| 245 | 0 | 0 |
_aTolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cSep 2008 |
||
| 300 |
_a1430-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoxazoles _xadverse effects |
| 650 | 0 | 4 | _aLeflunomide |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aO'Reilly, D T | |
| 700 | 1 | _aSlack, R K | |
| 700 | 1 | _aCollins, D | |
| 700 | 1 | _aWalmsley, J | |
| 700 | 1 | _aDuke, O | |
| 700 | 1 | _aKiely, P D W | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 47 _gno. 9 _gp. 1430-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/ken240 _zAvailable from publisher's website |
| 999 |
_c18109050 _d18109050 |
||